Compile Data Set for Download or QSAR
Report error Found 230 Enz. Inhib. hit(s) with all data for entry = 11427
TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616065BDBM616065(US20230271964, Example 1-22)
Affinity DataKi:  0.0790nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616103BDBM616103(US20230271964, Example 1-60 | US20230271964, Examp...)
Affinity DataKi:  0.0790nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616110BDBM616110(US20230271964, Example 1-67)
Affinity DataKi:  0.100nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616097BDBM616097(US20230271964, Example 1-54 | US20230271964, Examp...)
Affinity DataKi:  0.100nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616108BDBM616108(US20230271964, Example 1-65)
Affinity DataKi:  0.100nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616102BDBM616102(US20230271964, Example 1-59)
Affinity DataKi:  0.126nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616103BDBM616103(US20230271964, Example 1-60 | US20230271964, Examp...)
Affinity DataKi:  0.126nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616054BDBM616054(US20230271964, Example 1-11)
Affinity DataKi:  0.158nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616098BDBM616098(US20230271964, Example 1-55 | US20230271964, Examp...)
Affinity DataKi:  0.158nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616097BDBM616097(US20230271964, Example 1-54 | US20230271964, Examp...)
Affinity DataKi:  0.200nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616109BDBM616109(US20230271964, Example 1-66)
Affinity DataKi:  0.200nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616138BDBM616138(US20230271964, Example 2-27)
Affinity DataKi:  0.251nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616104BDBM616104(US20230271964, Example 1-61 | US20230271964, Examp...)
Affinity DataKi:  0.251nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616062BDBM616062(US20230271964, Example 1-19)
Affinity DataKi:  0.251nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616143BDBM616143(US20230271964, Example 2-32 | US20230271964, Examp...)
Affinity DataKi:  0.251nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616074BDBM616074(US20230271964, Example 1-31)
Affinity DataKi:  0.251nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616107BDBM616107(US20230271964, Example 1-64)
Affinity DataKi:  0.251nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616104BDBM616104(US20230271964, Example 1-61 | US20230271964, Examp...)
Affinity DataKi:  0.316nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616081BDBM616081(US20230271964, Example 1-38)
Affinity DataKi:  0.316nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616143BDBM616143(US20230271964, Example 2-32 | US20230271964, Examp...)
Affinity DataKi:  0.316nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616101BDBM616101(US20230271964, Example 1-58)
Affinity DataKi:  0.316nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616093BDBM616093(US20230271964, Example 1-50)
Affinity DataKi:  0.316nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616082BDBM616082(US20230271964, Example 1-39 | US20230271964, Examp...)
Affinity DataKi:  0.316nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616082BDBM616082(US20230271964, Example 1-39 | US20230271964, Examp...)
Affinity DataKi:  0.316nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616075BDBM616075(US20230271964, Example 1-32)
Affinity DataKi:  0.316nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616094BDBM616094(US20230271964, Example 1-51)
Affinity DataKi:  0.398nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616145BDBM616145(US20230271964, Example 2-34)
Affinity DataKi:  0.398nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616098BDBM616098(US20230271964, Example 1-55 | US20230271964, Examp...)
Affinity DataKi:  0.398nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616059BDBM616059(US20230271964, Example 1-16)
Affinity DataKi:  0.398nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616088BDBM616088(US20230271964, Example 1-45)
Affinity DataKi:  0.501nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616089BDBM616089(US20230271964, Example 1-46)
Affinity DataKi:  0.501nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616117BDBM616117(US20230271964, Example 2-7)
Affinity DataKi:  0.501nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616140BDBM616140(US20230271964, Example 2-29 | US20230271964, Examp...)
Affinity DataKi:  0.501nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616096BDBM616096(US20230271964, Example 1-53)
Affinity DataKi:  0.631nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616146BDBM616146(US20230271964, Example 2-35 | US20230271964, Examp...)
Affinity DataKi:  0.631nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616057BDBM616057(US20230271964, Example 1-14)
Affinity DataKi:  0.631nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616127BDBM616127(US20230271964, Example 2-16)
Affinity DataKi:  0.631nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616053BDBM616053(US20230271964, Example 1-10)
Affinity DataKi:  0.631nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616077BDBM616077(US20230271964, Example 1-34)
Affinity DataKi:  0.631nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616067BDBM616067(US20230271964, Example 1-24)
Affinity DataKi:  0.631nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616146BDBM616146(US20230271964, Example 2-35 | US20230271964, Examp...)
Affinity DataKi:  0.794nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616139BDBM616139(US20230271964, Example 2-28)
Affinity DataKi:  0.794nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616086BDBM616086(US20230271964, Example 1-43)
Affinity DataKi:  0.794nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616052BDBM616052(US20230271964, Example 1-9)
Affinity DataKi:  0.794nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616084BDBM616084(US20230271964, Example 1-41 | US20230271964, Examp...)
Affinity DataKi:  0.794nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616116BDBM616116(US20230271964, Example 2-6)
Affinity DataKi:  0.794nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616118BDBM616118(US20230271964, Example 2-8)
Affinity DataKi:  1nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616055BDBM616055(US20230271964, Example 1-12)
Affinity DataKi:  1nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616148BDBM616148(US20230271964, Example 2-37)
Affinity DataKi:  1nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 616140BDBM616140(US20230271964, Example 2-29 | US20230271964, Examp...)
Affinity DataKi:  1nMAssay Description:Inhibition binding assays were performed using 0.2 µg of membranes prepared from HEK293 cells infected with BacMam human adenosine A2A receptor or 1....More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2023
Entry Details
US Patent

Displayed 1 to 50 (of 230 total ) | Next | Last >>
Jump to: